Notch | $15,000,000 | (Oct 2, 2025)
Clarifeye | $4,693,900 | (Oct 2, 2025)
Ankored | $4,000,000 | (Oct 2, 2025)
Certified by Founder
Lodge
RheumaGen
start up
United States
- Denver, Colorado
- 10/01/2025
- Series A
- $15,000,000
RheumaGen is a private biotechnology company engineering a new class of therapeutics to cure major autoimmune diseases at their source. RheumaGen focuses on editing the human leukocyte antigen (HLA), or “immune gene,” to develop one-time, curative cell and gene therapies. RheumaGen is headquartered in Aurora, Colorado. For more information, please visit rheumagen.com.
- Industry Biotechnology Research
- Website https://www.rheumagen.com/
- LinkedIn https://www.linkedin.com/company/rheumagen/
Prosper AI | $5,000,000 | (Oct 2, 2025)
Gelt | $13,000,000 | (Oct 2, 2025)
Returnalyze | $6,000,000 | (Oct 2, 2025)
Hupside | $1,700,000 | (Oct 2, 2025)
Athernal Bio | $4,718,630 | (Oct 2, 2025)
Price.com | $12,000,000 | (Oct 2, 2025)
Mondoo | $17,500,000 | (Oct 2, 2025)
SolidCore.ai | $4,000,000 | (Oct 2, 2025)